Human cancer and gene therapy
- PMID: 7993934
- DOI: 10.1007/BF01696555
Human cancer and gene therapy
Similar articles
-
The emerging fields of suicide gene therapy and virotherapy.Trends Mol Med. 2002;8(4 Suppl):S68-73. doi: 10.1016/s1471-4914(02)02318-3. Trends Mol Med. 2002. PMID: 11927291 Review.
-
Viral vector systems for gene therapy.Cancer Gene Ther. 1994 Mar;1(1):51-64. Cancer Gene Ther. 1994. PMID: 7621239 Review. No abstract available.
-
Use of suicide genes for cancer gene therapy: study of the different approaches.Expert Opin Biol Ther. 2004 Apr;4(4):519-30. doi: 10.1517/14712598.4.4.519. Expert Opin Biol Ther. 2004. PMID: 15102601 Review.
-
[Current status of gene therapy and viral vectors].Uirusu. 1997 Dec;47(2):195-201. doi: 10.2222/jsv.47.195. Uirusu. 1997. PMID: 9545865 Review. Japanese. No abstract available.
-
Prospects for human gene therapy.Eur J Drug Metab Pharmacokinet. 1996 Apr-Jun;21(2):175-9. doi: 10.1007/BF03190267. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8839692 Review.
Cited by
-
A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.Gene Ther. 2010 Nov;17(11):1325-32. doi: 10.1038/gt.2010.63. Epub 2010 Apr 29. Gene Ther. 2010. PMID: 20428214 Free PMC article.
-
Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.Breast Cancer Res. 2009;11(4):R53. doi: 10.1186/bcr2342. Epub 2009 Jul 27. Breast Cancer Res. 2009. PMID: 19635153 Free PMC article.
-
The use of the NIS reporter gene for optimizing oncolytic virotherapy.Expert Opin Biol Ther. 2016;16(1):15-32. doi: 10.1517/14712598.2016.1100162. Epub 2015 Oct 12. Expert Opin Biol Ther. 2016. PMID: 26457362 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical